We are live on ! Find out more
ARRY

Array Biopharma Inc
ARRY

Delisted

ARRY was delisted on the 29th of July, 2019.

Back to rankings

133 hedge funds and large institutions have $1.05B invested in Array Biopharma Inc in 2015 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 55 increasing their positions, 35 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 15

79% more capital invested

Capital invested by funds: $586M → $1.05B (+$464M)

57% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 35

32% more call options, than puts

Call options by funds: $25.1M | Put options by funds: $19M

9% more funds holding

Funds holding: 122 → 133 (+11)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
133
Holders Change
+11
Holders Change %
+9.02%
% of All Funds
3.54%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
27
Increased
55
Reduced
35
Closed
15
Calls
$25.1M
Puts
$19M
Net Calls
+$6.1M
Net Calls Change
+$5.59M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$52.1M
2
BBA
Baker Bros. Advisors
New York
+$30.1M
3
O
OrbiMed
New York
+$14.1M
4
Invesco
Invesco
Georgia
+$12.9M
5
Millennium Management
Millennium Management
New York
+$11.9M

Top Sellers

1
BI
BVF Inc
California
-$16.8M
2
BA
BlackRock Advisors
Delaware
-$8.27M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$7.72M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$4.27M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$3.93M
Name Holding Trade Value Shares
Change 		Change in
Stake
WMSA
51
Weiss Multi-Strategy Advisers
New York
$1.52M +$46.3K +6,500 +3%
Barclays
52
Barclays
United Kingdom
$1.5M +$48K +6,748 +3%
OPPM
53
Opus Point Partners Management
New York
$1.47M – – –
GC
54
Guggenheim Capital
Illinois
$1.47M +$1.31M +184,362 +1,186%
AllianceBernstein
55
AllianceBernstein
Tennessee
$1.46M -$34.9K -4,900 -2%
CS
56
Credit Suisse
Switzerland
$1.44M -$514K -72,269 -27%
TA
57
Teachers Advisors
New York
$1.43M +$118K +16,547 +9%
Two Sigma Advisers
58
Two Sigma Advisers
New York
$1.43M +$851K +119,600 +161%
CGT
59
Capital Guardian Trust
California
$1.29M -$890K -125,000 -42%
HCM
60
Hollencrest Capital Management
California
$1.25M – – –
BFIC
61
Bedell Frazier Investment Counselling
California
$1.25M -$21.9K -3,070 -2%
JP Morgan Chase
62
JP Morgan Chase
New York
$1.2M +$1.06M +148,751 +1,094%
EI
63
EAM Investors
California
$1.1M +$1.06M +149,121 New
HI
64
HBK Investments
Texas
$1.06M +$1.03M +144,150 New
Swiss National Bank
65
Swiss National Bank
Switzerland
$1.06M – – –
RhumbLine Advisers
66
RhumbLine Advisers
Massachusetts
$1.04M +$134K +18,825 +15%
Wells Fargo
67
Wells Fargo
California
$1.03M -$97.6K -13,703 -9%
ProShare Advisors
68
ProShare Advisors
Maryland
$1.03M +$179K +25,199 +22%
RFC
69
Russell Frank Company
Washington
$952K +$919K +129,157 New
TI
70
Telemetry Investments
New York
$936K +$904K +127,000 New
MLICM
71
Metropolitan Life Insurance Company (MetLife)
New York
$768K +$27.1K +3,806 +4%
NFA
72
Nationwide Fund Advisors
Ohio
$707K +$3.55K +499 +0.5%
EMG
73
Ellington Management Group
Connecticut
$700K +$676K +95,000 New
BA
74
BlackRock Advisors
Delaware
$654K -$8.27M -1,162,081 -93%
TI
75
Trexquant Investment
Connecticut
$635K +$614K +86,212 New
1 2
3
4 5

ARRY Hedge Fund Activity: Q1 2015 in Review

133 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Array Biopharma Inc (ARRY) for Q1 2015, worth a combined $1.05B — up 79% from $586M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new ARRY positions and 15 closed out — a net gain of 12 holders — while 55 added to existing stakes and 35 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $52.1M. The largest seller was BVF Inc, cutting an estimated $16.8M.

  • 133 institutional investors held Array Biopharma Inc (ARRY) as of Q1 2015, up from 122 in Q4 2014.
  • Funds reported $1.05B of Array Biopharma Inc stock for Q1 2015, up 79% quarter-over-quarter.
  • 27 funds opened new Array Biopharma Inc positions in Q1 2015 and 15 closed out, a net change of +12 holders.
  • The largest Array Biopharma Inc buyer in Q1 2015 was Fidelity Investments, an estimated $52.1M added.
  • The largest Array Biopharma Inc seller in Q1 2015 was BVF Inc, an estimated $16.8M sold.

Based on aggregated 13F filings for Q1 2015.